SCHEMBL8553947

SCHEMBL8553947

CC(CNC(=O)c1ccc2c(c1)CCOC2)N1CCN(c2ccc(Cl)cc2Cl)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.41
LMNA P02545 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
MAPT P10636 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HTT P42858 2/20 0.40
MAPK1 P28482 1/20 0.40
CXCR3 P49682 4/20 0.39
NPSR1 Q6W5P4 3/20 0.39
USP2 O75604 1/20 0.39
TSHR P16473 1/20 0.39
TP53 P04637 2/20 0.38
THRB P10828 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
DRD2 P14416 3/20 0.38
DRD3 P35462 3/20 0.38
ALDH1A1 P00352 1/20 0.37
NTSR1 P30989 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8627748 0.83 MEN1 (0.45) LMNASMN1; SMN2MAPTMEN1KMT2A
SCHEMBL8550428 0.83 ALDH1A1 (0.52) LMNAHTTDRD2DRD3ALDH1A1
SCHEMBL8549102 0.81 SMN1; SMN2 (0.39) LMNASMN1; SMN2MAPTMEN1KMT2A
SCHEMBL8550140 0.80 NAMPT (0.45) LMNASMN1; SMN2MAPTTP53DRD2
SCHEMBL8551580 0.80 ALDH1A1 (0.38) LMNASMN1; SMN2MAPTMEN1KMT2A
SCHEMBL8550899 0.78 LMNA (0.37) AKR1C3LMNASMN1; SMN2MAPTMEN1
SCHEMBL8549848 0.76 DRD2 (0.43) LMNAMAPTTP53DRD2
SCHEMBL8550516 0.74 DRD4 (0.47) AKR1C3LMNASMN1; SMN2MAPTMEN1
SCHEMBL8549399 0.68 CCR3 (0.56) MAPTKMT2ADRD2DRD3DRD4
SCHEMBL8549874 0.66 MEN1 (0.44) LMNASMN1; SMN2MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0836599-A1 1,6-DISUBSTITUTED ISOCHROMANS FOR TREATMENT OF MIGRAINE HEADACHES PHARMACIA & UPJOHN COMPANY (US) 1998-04-22 EP disclosed